Search the database for deliberate release of GM medicinal products
Displaying 1 - 1 of 1
|EU record number
|Company / Sponsor
|Only notified under the "contained use" procedure. Dossier submitted on 13/10/2000.
|A phase III open-label, comparative, multicentre trials to test the concept of durable virologic suppression in subjects with primary HIV-1 infection after intensive induction of quadruple HAART followed by double-blind randomization to HIV vaccination wi